secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cencora, Inc. (COR)
CIK:        0001140859
Form:       8-K
Filed at:   2025-03-10T23:59:59+00:00
Accession:  0001104659-25-021947
Event type: earnings
Sentiment:  positive
Materiality: 0.25
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Cencora raises FY2025 adjusted EPS guidance range by $0.05 to $15.30-$15.60
---------------------------------------------------------------------------

- Guidance increase driven by continued momentum in U.S. Healthcare Solutions segment during Q2 2025.
- No change to expectations for recently completed Retina Consultants of America acquisition.
- Adjusted diluted EPS excludes acquisition intangibles, LIFO, litigation, and other items.
- Company presented updated guidance at Leerink Partners Global Healthcare Conference on March 10, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1140859/000110465925021947/0001104659-25-021947-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1140859/000110465925021947/tm258653d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-021947

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer